Ruchika Chitravanshi And Nivedita Mookerji

Stories by Ruchika Chitravanshi And Nivedita Mookerji

How the new Companies Act will affect Tata Sons, Bharti Telecom

How the new Companies Act will affect Tata Sons, Bharti Telecom

Rediff.com   22 Feb 2021

Companies such as Tata Sons and Bharti Telecom, which are unlisted but have listed subsidiaries, may soon have to file periodic financial statements with the registrar of companies under the new provision of the Companies Act. The provision requires greater financial disclosures by a certain category of unlisted companies.

Public may get COVID-19 vaccine by April

Public may get COVID-19 vaccine by April

Rediff.com   22 Feb 2021

Anybody over 50 years of age or with co-morbidities can get a date, place and time of choice for getting the vaccine shots.

After a year of Covid, India may not face a second wave

After a year of Covid, India may not face a second wave

Rediff.com   9 Feb 2021

Epidemiologists point out that if there is no second wave, it means that the number of infected has surpassed the uninfected, reports Ruchika Chitravanshi.

'Covid vaccination will be like RAC'

'Covid vaccination will be like RAC'

Rediff.com   3 Feb 2021

'People on the wait list will be accommodated for vaccination when the scheduled beneficiaries don't turn up.'

Despite Covid, registration of new companies went up in 2020

Despite Covid, registration of new companies went up in 2020

Rediff.com   24 Jan 2021

Moreover, 5,611 companies struck off earlier by the ministry of corporate affairs because of compliance-related lacunae, were registered again.

Trusts, societies have to register with MCA by April 1

Trusts, societies have to register with MCA by April 1

Rediff.com   23 Jan 2021

Corporate social responsibility rules that kicked in on Friday also set a three year time-limit for any CSR project, among a series of other amendments introduced by the government.

Covaxin has tolerable safety: Lancet

Covaxin has tolerable safety: Lancet

Rediff.com   23 Jan 2021

The vaccine was well tolerated in all dose groups with no vaccine-related adverse events.

Budget 2021: Sharper focus on health care likely

Budget 2021: Sharper focus on health care likely

Rediff.com   20 Jan 2021

CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.

Govt proposes phase-wise pre-packed insolvency process

Govt proposes phase-wise pre-packed insolvency process

Rediff.com   18 Jan 2021

A draft proposal by the sub-committee of the insolvency law committee has recommended that the corporate debtor (CD) may initiate the prepack since it may prove difficult to implement if creditors are allowed to do so without the willingness of the promoter.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com   16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com   29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com   23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

Is India's 5G dream in trouble?

Is India's 5G dream in trouble?

Rediff.com   21 Dec 2020

Nivedita Mookerji explains why a timely rollout of 5G may not be easy in India.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com   19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com   16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Online disrupts India's wholesale business

Online disrupts India's wholesale business

Rediff.com   30 Nov 2020

Online play is a priority now -- so far unthinkable in a business that's all about a meaningful interface with kirana stores.

Govt to decriminalise provisions of LLP Act

Govt to decriminalise provisions of LLP Act

Rediff.com   23 Nov 2020

One of the changes being proposed is allowing LLPs to issue non-convertible debentures.